Delivery Order SPE2DB24D2003-SPE2DB25FXHP8

Award Date 5/12/25
Potential Completion Date 5/13/25
Potential Value $1.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $10,351.99 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of ADVAIR HFA 115-21 MCG INHALER 12GM. The order has an ultimate completion date of August 14, 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up to $999,999,999 through December 2025 for delivering a range of medical commodities to support military...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The order is for 4,564,376,679 units of the ADVAIR HFA 115-21 MCG INHALER 12GM, a pharmaceutical product, with a total ceiling value of $6,957.55 and a completion date of April 24, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999 through November 2026, which...
This is a $28,143.31 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of the ADVAIR HFA 115-21 MCG INHALER 12GM medication. The contract has an ultimate completion date of July 7, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, designated as SPE2DX, which provides a comprehensive...
This is a $1,043.16 firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of ADVAIR HFA 45-21 MCG INHALER 12GM, a prescription medication, with a period of performance through June 25, 2025. The award is not associated with a set-aside program. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support...
This is a $5,925.51 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The order is for ADVAIR HFA 115-21 MCG INHALER 12GM, a prescription medication. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support vehicle...
This is a $24,140.34 firm fixed-price delivery order awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) Troop Support Medical. The award covers the supply of ADVAIR HFA 115-21 MCG INHALER 12GM, a pharmaceutical product, for the government. The contract has an ultimate completion date of June 25, 2024 and was awarded on June 24, 2024. This delivery order is part of Amerisourcebergen's larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,458,621 units of ADVAIR HFA 230-21 MCG INHALER 12GM. The $2,117.85 contract has a completion date of January 29, 2024. Amerisourcebergen Drug Corp is the prime contractor, with no set-aside designation. This delivery order is part of a larger $999,999,999.00 indefinite delivery contract (IDC)...
This is a $3,544.56 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the supply of ADVAIR HFA 230-21 MCG INHALER 12GM, a prescription medication. It has an ultimate completion date of May 30, 2025. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with DLA Troop Support Medical,...
This is a $3,006.90 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for ADVAIR HFA 115-21 MCG INHALER 12GM, a prescription medication. The contract has a period of performance through May 8, 2024 and was awarded on May 7, 2024. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
This is a $3,908.22 firm fixed-price delivery order awarded to Amerisourcebergen Drug Corp, Corporate Office Division by the Defense Logistics Agency (DLA) for the supply of ADVAIR HFA 115-21 MCG INHALER 12GM. The delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, which has a ceiling value of up to $999,999,999 and runs through December 2025. This contract supports the DLA's role in providing pharmaceutical and...
  • SPE2DB24D2003
    Indefinite Delivery Contract
  • SPE2DB24D2003-SPE2DB25FXHP8
    Delivery Order

This is a $1,844.25 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The order is for 4,568,216,853 units of the prescription medication ADVAIR HFA 115-21 MCG INHALER 12GM. The delivery order is not set aside and has an ultimate completion date of May 13, 2025.

Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, designated as SPE2DX, which provides a comprehensive global pharmaceutical support vehicle with a performance period through December 2026. This IDC enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers including the Defense Health Agency and U.S. Coast Guard.

Generated 8/17/25, 1:09 AM